Grant agency · HHS-NIH11
National Institutes of Health
Review 375 notices from this Grants.gov agency code across 54 listed federal programs.
Agency notices
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-27-002 · National Institutes of Health · November 10, 2026 · 93.394
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) RFA-NS-26-001 · National Institutes of Health · November 10, 2026 · 93.853
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) RFA-AI-27-005 · National Institutes of Health · November 10, 2026 · 93.855
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) RFA-AG-27-010 · National Institutes of Health · November 10, 2026 · 93.866
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) RFA-CA-27-001 · National Institutes of Health · November 10, 2026 · 93.394
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) RFA-AI-27-002 · National Institutes of Health · November 10, 2026 · 93.855
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) RFA-OD-27-009 · National Institutes of Health · November 10, 2026 · 93.310, 93.859
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) PAR-25-270 · National Institutes of Health · November 13, 2026 · 93.213
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) PAR-25-269 · National Institutes of Health · November 13, 2026 · 93.213
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) PAR-25-271 · National Institutes of Health · November 13, 2026 · 93.213
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) PAR-24-089 · National Institutes of Health · November 13, 2026 · 93.279
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) PAR-25-370 · National Institutes of Health · November 16, 2026 · 93.113, 93.121, 93.172, 93.173, 93.242, 93.279, 93.310, 93.313, 93.399, 93.855, 93.865, 93.989
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) PAR-25-274 · National Institutes of Health · November 17, 2026 · 93.213
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) PAR-25-268 · National Institutes of Health · November 17, 2026 · 93.213
- NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) PAR-25-267 · National Institutes of Health · November 17, 2026 · 93.213
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) PAR-25-158 · National Institutes of Health · November 17, 2026 · 93.273
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) PAR-25-096 · National Institutes of Health · November 17, 2026 · 93.121, 93.172, 93.393, 93.866
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) RFA-DK-27-122 · National Institutes of Health · November 17, 2026 · 93.847
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) PAR-25-369 · National Institutes of Health · November 18, 2026 · 93.113, 93.121, 93.172, 93.173, 93.242, 93.279, 93.310, 93.313, 93.399, 93.853, 93.855, 93.865, 93.867, 93.989
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) PAR-25-371 · National Institutes of Health · November 18, 2026 · 93.113, 93.172, 93.173, 93.242, 93.279, 93.307, 93.310, 93.313, 93.399, 93.853, 93.855, 93.865, 93.867
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) PAR-25-052 · National Institutes of Health · November 19, 2026 · 93.853
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) PAR-25-226 · National Institutes of Health · November 19, 2026 · 93.242
- Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) RFA-RM-27-016 · National Institutes of Health · November 23, 2026 · 93.310
- Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) RFA-RM-27-025 · National Institutes of Health · November 23, 2026 · 93.310
- Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) RFA-RM-27-007 · National Institutes of Health · November 23, 2026 · 93.310
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) RFA-AT-25-003 · National Institutes of Health · November 23, 2026 · 93.121, 93.213, 93.273, 93.846, 93.853, 93.865, 93.866
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) PA-23-317 · National Institutes of Health · November 24, 2026 · 93.172, 93.213, 93.242, 93.273, 93.279, 93.307, 93.310, 93.350, 93.394, 93.865, 93.866, 93.867
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) RFA-OD-27-008 · National Institutes of Health · December 2, 2026 · 93.121, 93.307, 93.310, 93.313, 93.361, 93.853
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) PAR-24-296 · National Institutes of Health · December 3, 2026 · 93.113, 93.121, 93.172, 93.173, 93.233, 93.242, 93.279, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.867, 93.989
- Emerging Global Leader Award (K43 Independent Clinical Trial Required) PAR-24-295 · National Institutes of Health · December 3, 2026 · 93.113, 93.172, 93.173, 93.233, 93.242, 93.279, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.989
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) RFA-OD-24-011 · National Institutes of Health · December 4, 2026 · 93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.396, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867, 93.879
- Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed) RFA-HG-27-010 · National Institutes of Health · December 14, 2026 · 93.172
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) RFA-HG-27-009 · National Institutes of Health · December 14, 2026 · 93.172
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) RFA-HG-27-008 · National Institutes of Health · December 14, 2026 · 93.172
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed) RFA-HG-27-007 · National Institutes of Health · December 14, 2026 · 93.172
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-24-214 · National Institutes of Health · January 7, 2027 · 93.173, 93.233, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, 93.867
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) PAR-25-079 · National Institutes of Health · January 7, 2027 · 93.394, 93.395
- Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) PAR-25-310 · National Institutes of Health · January 7, 2027 · 93.242
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-25-167 · National Institutes of Health · January 7, 2027 · 93.393, 93.399
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) PAR-25-256 · National Institutes of Health · January 7, 2027 · 93.172, 93.399
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) PAR-25-379 · National Institutes of Health · January 7, 2027 · 93.113, 93.121, 93.173, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.879
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) PAR-25-378 · National Institutes of Health · January 7, 2027 · 93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.310, 93.313, 93.361, 93.865, 93.866
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) PAR-25-098 · National Institutes of Health · January 7, 2027 · 93.121, 93.307, 93.313, 93.399
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) PAR-25-069 · National Institutes of Health · January 7, 2027 · 93.393
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) PAR-25-070 · National Institutes of Health · January 7, 2027 · 93.393
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) PAR-25-081 · National Institutes of Health · January 7, 2027 · 93.393, 93.394, 93.395, 93.399
- Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) PAR-25-235 · National Institutes of Health · January 7, 2027 · 93.242, 93.879
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) PAR-25-221 · National Institutes of Health · January 7, 2027 · 93.273, 93.396
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) PAR-25-159 · National Institutes of Health · January 7, 2027 · 93.273
- Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed) RFA-RM-27-010 · National Institutes of Health · January 8, 2027 · 93.310
- Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) RFA-RM-27-008 · National Institutes of Health · January 8, 2027 · 93.310
- Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed) RFA-RM-27-009 · National Institutes of Health · January 8, 2027 · 93.310
- Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) PAR-27-071 · National Institutes of Health · January 11, 2027 · 93.310
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) RFA-CA-27-005 · National Institutes of Health · January 11, 2027 · 93.394, 93.395
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) RFA-NS-25-023 · National Institutes of Health · January 15, 2027 · 93.121, 93.213, 93.273, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867
- Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) PAR-28-062 · National Institutes of Health · January 25, 2027 · 93.399
- Medical Scientist Training Program (MSTP) (T32) PAR-24-128 · National Institutes of Health · January 25, 2027 · 93.859
- Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32) PAR-24-235 · National Institutes of Health · January 25, 2027 · 93.859
- Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34) PAR-24-236 · National Institutes of Health · January 25, 2027 · 93.859
- HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) RFA-DA-28-012 · National Institutes of Health · January 26, 2027 · 93.213, 93.273, 93.279, 93.853, 93.866
- HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) RFA-DA-28-011 · National Institutes of Health · January 26, 2027 · 93.213, 93.273, 93.279, 93.853, 93.866
- National Centers for Cryo-electron Tomography (cryoET) (R24 -Clinical Trial Not Allowed) PAR-26-138 · National Institutes of Health · January 26, 2027 · 93.859
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) PAR-24-268 · National Institutes of Health · January 27, 2027 · 93.121, 93.213, 93.242, 93.273, 93.279, 93.310, 93.846, 93.853, 93.859, 93.866, 93.867
- Diabetes Research Centers (P30 Clinical Trial Optional) RFA-DK-26-310 · National Institutes of Health · January 27, 2027 · 93.847
- Specialized Alcohol Research Centers (P50 Clinical trial Optional) RFA-AA-28-001 · National Institutes of Health · January 27, 2027 · 93.273
- Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed) PAR-24-260 · National Institutes of Health · January 27, 2027 · 93.859
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) RFA-NS-24-031 · National Institutes of Health · January 28, 2027 · 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867
- Translational Neural Devices (R61/R33 - Clinical Trial Optional) PAR-25-053 · National Institutes of Health · January 28, 2027 · 93.853
- Immune Tolerance Network (UM1 Clinical Trial Required) RFA-AI-28-005 · National Institutes of Health · January 29, 2027 · 93.855
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) RFA-AI-28-012 · National Institutes of Health · January 29, 2027 · 93.310, 93.855
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional) RFA-DK-28-314 · National Institutes of Health · February 1, 2027
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) PAR-25-025 · National Institutes of Health · February 3, 2027 · 93.233, 93.837, 93.838, 93.839
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) PAR-25-026 · National Institutes of Health · February 3, 2027 · 93.233, 93.837, 93.838, 93.839, 93.840
- BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) RFA-MH-26-170 · National Institutes of Health · February 8, 2027 · 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867
- Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) RFA-DA-28-013 · National Institutes of Health · February 8, 2027 · 93.279
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) RFA-CA-28-013 · National Institutes of Health · February 9, 2027 · 93.393, 93.396, 93.399
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) RFA-DK-27-119 · National Institutes of Health · February 10, 2027 · 93.847
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) RFA-AI-28-024 · National Institutes of Health · February 11, 2027 · 93.855
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) RFA-DC-27-004 · National Institutes of Health · February 11, 2027 · 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) RFA-CA-28-004 · National Institutes of Health · February 11, 2027 · 93.394
- NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) PAR-24-269 · National Institutes of Health · February 11, 2027 · 93.279
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) RFA-LM-28-001 · National Institutes of Health · February 11, 2027 · 93.121, 93.173, 93.242, 93.279, 93.310, 93.398, 93.853, 93.855, 93.867, 93.879
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed) RFA-AI-28-014 · National Institutes of Health · February 18, 2027 · 93.121, 93.172, 93.543
- Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) RFA-HG-25-009 · National Institutes of Health · February 26, 2027 · 93.172
- Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed) PAR-27-069 · National Institutes of Health · March 1, 2027 · 93.368
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR-25-141 · National Institutes of Health · March 4, 2027 · 93.846
- Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed) RFA-DC-28-002 · National Institutes of Health · March 5, 2027 · 93.173
- Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) PAR-27-081 · National Institutes of Health · March 5, 2027 · 93.242, 93.279, 93.866, 93.867
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) RFA-DA-25-060 · National Institutes of Health · March 5, 2027 · 93.279
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed) RFA-DK-28-213 · National Institutes of Health · March 5, 2027
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed) RFA-DK-28-214 · National Institutes of Health · March 5, 2027
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) RFA-DA-25-024 · National Institutes of Health · March 6, 2027 · 93.279
- Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) PAR-26-116 · National Institutes of Health · March 6, 2027 · 93.313
- Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) PAR-25-317 · National Institutes of Health · March 6, 2027 · 93.273, 93.307, 93.310, 93.313, 93.361, 93.399
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) RFA-DK-27-108 · National Institutes of Health · March 10, 2027 · 93.233, 93.837, 93.838, 93.839, 93.840, 93.847
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) PAR-25-032 · National Institutes of Health · March 16, 2027 · 93.233, 93.837, 93.838, 93.839, 93.840
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 · National Institutes of Health · April 5, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 · National Institutes of Health · April 5, 2027 · 93.068, 93.070, 93.073, 93.083, 93.084, 93.103, 93.113, 93.121, 93.136, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.326, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) RFA-OD-25-003 · National Institutes of Health · April 9, 2027 · 93.121, 93.173, 93.213, 93.233, 93.242, 93.279, 93.313, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847
- Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) PAR-25-131 · National Institutes of Health · April 15, 2027 · 93.879
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) PA-24-201 · National Institutes of Health · April 18, 2027 · 93.113, 93.142, 93.143, 93.279, 93.307, 93.846
- Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional) RFA-ES-25-002 · National Institutes of Health · April 20, 2027 · 93.113
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) RFA-HL-26-003 · National Institutes of Health · April 28, 2027 · 93.233, 93.837, 93.838, 93.839, 93.840
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) RFA-HL-26-002 · National Institutes of Health · April 28, 2027 · 93.233, 93.837, 93.838, 93.839, 93.840
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) PA-24-179 · National Institutes of Health · May 7, 2027 · 93.121, 93.273, 93.279, 93.310, 93.313, 93.853, 93.866
- Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) PA-24-178 · National Institutes of Health · May 7, 2027 · 93.273, 93.279, 93.310, 93.313, 93.853, 93.866
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) PA-24-185 · National Institutes of Health · May 7, 2027 · 93.113, 93.121, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) PA-24-191 · National Institutes of Health · May 7, 2027 · 93.113, 93.121, 93.172, 93.173, 93.233, 93.273, 93.279, 93.286, 93.310, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) PA-24-190 · National Institutes of Health · May 7, 2027 · 93.113, 93.173, 93.233, 93.273, 93.279, 93.286, 93.310, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847, 93.865, 93.866, 93.879
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) PA-24-176 · National Institutes of Health · May 7, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.351, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) PA-24-175 · National Institutes of Health · May 7, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.865, 93.866, 93.879
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) PA-24-188 · National Institutes of Health · May 7, 2027 · 93.113, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.866
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) PA-24-187 · National Institutes of Health · May 7, 2027 · 93.113, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.310, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.866
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) PAR-25-279 · National Institutes of Health · May 7, 2027 · 93.286, 93.396, 93.865, 93.866
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) PAR-25-272 · National Institutes of Health · May 7, 2027 · 93.396, 93.865, 93.866
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required) PAR-24-149 · National Institutes of Health · May 7, 2027 · 93.173
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Clinical Trial Not Allowed) PAR-24-159 · National Institutes of Health · May 7, 2027 · 93.173
- NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Not Allowed) PAR-24-143 · National Institutes of Health · May 7, 2027 · 93.173
- NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required) PAR-24-140 · National Institutes of Health · May 7, 2027 · 93.173
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) PA-24-194 · National Institutes of Health · May 7, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) PA-24-193 · National Institutes of Health · May 7, 2027 · 93.113, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.865, 93.866, 93.879
- Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) PAR-26-001 · National Institutes of Health · May 7, 2027 · 93.121, 93.273, 93.279, 93.307, 93.313, 93.399
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) PA-24-182 · National Institutes of Health · May 8, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) PA-24-181 · National Institutes of Health · May 8, 2027 · 93.113, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, 93.879
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) PA-24-184 · National Institutes of Health · May 8, 2027 · 93.113, 93.121, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.859, 93.865, 93.866
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed) PAR-28-057 · National Institutes of Health · May 25, 2027 · 93.393
- NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed) RFA-AG-26-010 · National Institutes of Health · May 26, 2027 · 93.866
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed) RFA-AG-26-011 · National Institutes of Health · May 26, 2027 · 93.866
- Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) RFA-AI-28-031 · National Institutes of Health · May 28, 2027 · 93.310, 93.855
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) PAR-25-197 · National Institutes of Health · May 28, 2027 · 93.350
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) PAR-25-210 · National Institutes of Health · June 2, 2027 · 93.121, 93.213, 93.313, 93.393, 93.866
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) PAR-25-211 · National Institutes of Health · June 2, 2027 · 93.121, 93.213, 93.313, 93.393, 93.866
- NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) PAR-25-416 · National Institutes of Health · June 14, 2027 · 93.859
- BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) RFA-MH-26-140 · National Institutes of Health · June 15, 2027 · 93.173, 93.213, 93.242, 93.273, 93.286, 93.853, 93.865, 93.866, 93.867
- BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) RFA-MH-26-120 · National Institutes of Health · June 15, 2027 · 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867
- Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) RFA-DC-26-001 · National Institutes of Health · June 17, 2027 · 93.173
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) RFA-TR-25-002 · National Institutes of Health · July 2, 2027 · 93.350
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254 · National Institutes of Health · July 12, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.352, 93.353, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) PAR-24-211 · National Institutes of Health · July 12, 2027 · 93.233, 93.837, 93.838, 93.839, 93.840
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) PAR-24-209 · National Institutes of Health · July 12, 2027 · 93.233, 93.837, 93.838, 93.839, 93.840
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253 · National Institutes of Health · July 17, 2027 · 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.352, 93.353, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) PAR-25-101 · National Institutes of Health · August 11, 2027 · 93.279
- Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) PAR-24-293 · National Institutes of Health · August 18, 2027 · 93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.866, 93.867
- Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) PAR-25-112 · National Institutes of Health · September 7, 2027 · 93.173, 93.865
- Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) PAR-25-113 · National Institutes of Health · September 7, 2027 · 93.173, 93.865
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) PAR-24-325 · National Institutes of Health · September 7, 2027 · 93.286, 93.394, 93.395, 93.866, 93.867
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) PAR-24-330 · National Institutes of Health · September 7, 2027 · 93.233, 93.273, 93.307, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-25-080 · National Institutes of Health · September 7, 2027 · 93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.859, 93.866, 93.867, 93.879
- Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) PAR-25-325 · National Institutes of Health · September 10, 2027 · 93.393
- NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) PAR-24-301 · National Institutes of Health · September 25, 2027 · 93.865
- Clinical and Translational Science Award (UM1 Clinical Trial Optional) PAR-24-272 · National Institutes of Health · September 28, 2027 · 93.350
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) PAR-25-196 · National Institutes of Health · September 28, 2027 · 93.350
- Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) PAR-25-195 · National Institutes of Health · September 28, 2027 · 93.350
- Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) PAR-25-194 · National Institutes of Health · September 28, 2027 · 93.350
- Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) PAR-25-020 · National Institutes of Health · September 29, 2027 · 93.173
- BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) RFA-NS-27-015 · National Institutes of Health · October 4, 2027 · 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.372, 93.853, 93.865, 93.866, 93.867
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) PAR-25-327 · National Institutes of Health · October 8, 2027 · 93.853
- Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) PAR-25-248 · National Institutes of Health · October 8, 2027 · 93.393
- NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional) RFA-DC-25-002 · National Institutes of Health · October 12, 2027 · 93.173
- NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) PAR-25-135 · National Institutes of Health · October 14, 2027 · 93.398
- NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) PAR-25-313 · National Institutes of Health · October 14, 2027 · 93.398
- Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) PAR-25-179 · National Institutes of Health · October 15, 2027 · 93.242
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) PAR-25-181 · National Institutes of Health · October 15, 2027 · 93.242
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) PAR-25-182 · National Institutes of Health · October 15, 2027 · 93.242
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) PAR-25-183 · National Institutes of Health · October 15, 2027 · 93.242
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) PAR-25-184 · National Institutes of Health · October 15, 2027 · 93.242
- Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) PAR-25-285 · National Institutes of Health · October 15, 2027 · 93.242
- First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) PAR-25-180 · National Institutes of Health · October 15, 2027 · 93.242
- Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) PAR-25-177 · National Institutes of Health · October 15, 2027 · 93.242
- NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) PAR-25-120 · National Institutes of Health · October 15, 2027 · 93.173
- Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required) PAR-25-178 · National Institutes of Health · October 15, 2027 · 93.242
- NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) PAR-25-357 · National Institutes of Health · October 16, 2027 · 93.867
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) PAR-25-343 · National Institutes of Health · October 18, 2027 · 93.173
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) RFA-CA-27-019 · National Institutes of Health · October 19, 2027 · 93.393, 93.394, 93.395, 93.396, 93.399
- Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) PAR-25-296 · National Institutes of Health · October 19, 2027 · 93.121, 93.172, 93.307, 93.313, 93.350, 93.846, 93.855, 93.859, 93.865
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) PAR-25-060 · National Institutes of Health · October 20, 2027 · 93.853
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) PAR-25-059 · National Institutes of Health · October 20, 2027 · 93.853
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) PAR-25-225 · National Institutes of Health · October 20, 2027 · 93.853
- Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed) RFA-RM-27-024 · National Institutes of Health · October 22, 2027 · 93.310
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) PAR-25-104 · National Institutes of Health · October 25, 2027 · 93.399
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) PAR-25-103 · National Institutes of Health · October 25, 2027 · 93.399
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional) PAR-25-352 · National Institutes of Health · October 25, 2027 · 93.242
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional) PAR-25-353 · National Institutes of Health · October 25, 2027 · 93.242
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-27-078 · National Institutes of Health · October 25, 2027 · 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) PAR-25-100 · National Institutes of Health · October 27, 2027 · 93.279
- Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) RFA-MH-27-125 · National Institutes of Health · October 28, 2027 · 93.242, 93.279, 93.853
- National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed) RFA-DC-28-001 · National Institutes of Health · November 1, 2027 · 93.173
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) PAR-25-297 · National Institutes of Health · November 5, 2027 · 93.866
- Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required) PAR-25-149 · National Institutes of Health · November 5, 2027 · 93.853
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) PAS-25-073 · National Institutes of Health · November 5, 2027 · 93.847
- BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) RFA-DA-27-004 · National Institutes of Health · November 8, 2027 · 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.372, 93.853, 93.865, 93.866, 93.867
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) PAR-25-215 · National Institutes of Health · November 12, 2027 · 93.853
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) PAR-25-216 · National Institutes of Health · November 12, 2027 · 93.853
- NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) PAR-24-321 · National Institutes of Health · November 12, 2027 · 93.866
- Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) PAR-25-311 · National Institutes of Health · November 15, 2027 · 93.313, 93.865
- Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) PAR-25-336 · National Institutes of Health · November 15, 2027 · 93.395
- Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) PAR-25-244 · National Institutes of Health · November 16, 2027 · 93.393
- Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) PAR-25-265 · National Institutes of Health · November 16, 2027 · 93.865
- Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) PAR-25-266 · National Institutes of Health · November 16, 2027 · 93.865
- Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) PAR-25-122 · National Institutes of Health · November 16, 2027 · 93.121, 93.173, 93.242, 93.350, 93.853, 93.855
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) PAR-25-068 · National Institutes of Health · November 16, 2027 · 93.847
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) RFA-DA-26-034 · National Institutes of Health · November 18, 2027 · 93.233, 93.279, 93.837, 93.838, 93.839, 93.840, 93.855
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) RFA-DA-26-055 · National Institutes of Health · December 3, 2027 · 93.273, 93.279
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) RFA-DA-26-056 · National Institutes of Health · December 3, 2027 · 93.273, 93.279
- Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) RFA-HL-26-019 · National Institutes of Health · December 23, 2027 · 93.233, 93.837, 93.838, 93.839
- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) RFA-HL-26-016 · National Institutes of Health · December 23, 2027 · 93.233, 93.837, 93.838, 93.839
- Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) RFA-HL-26-020 · National Institutes of Health · December 23, 2027 · 93.233, 93.837, 93.838, 93.839
- Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) RFA-HL-26-017 · National Institutes of Health · December 23, 2027 · 93.233, 93.837, 93.838, 93.839, 93.855
- Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) RFA-HL-26-018 · National Institutes of Health · December 23, 2027 · 93.233, 93.837, 93.838, 93.839, 93.855
- Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required) PAR-25-062 · National Institutes of Health · January 6, 2028 · 93.121
- NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR-25-188 · National Institutes of Health · January 6, 2028 · 93.121
- NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR-25-057 · National Institutes of Health · January 6, 2028 · 93.121
- Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) PAS-25-205 · National Institutes of Health · January 6, 2028 · 93.839, 93.847, 93.866
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR-25-134 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-25-148 · National Institutes of Health · January 7, 2028 · 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867
- Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) PAR-25-338 · National Institutes of Health · January 7, 2028 · 93.121, 93.313, 93.394, 93.395, 93.867
- Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) PAR-25-337 · National Institutes of Health · January 7, 2028 · 93.394, 93.395
- Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) PAR-24-273 · National Institutes of Health · January 7, 2028 · 93.307, 93.361, 93.393, 93.866
- Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) PAR-25-243 · National Institutes of Health · January 7, 2028 · 93.393
- Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) PAR-25-145 · National Institutes of Health · January 7, 2028 · 93.393
- Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) PAR-25-273 · National Institutes of Health · January 7, 2028 · 93.351
- Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) PAR-25-024 · National Institutes of Health · January 7, 2028 · 93.853, 93.866
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) PAR-25-144 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.867
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) PAR-25-233 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.242, 93.273, 93.279, 93.310, 93.399, 93.853, 93.865, 93.866, 93.989
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) PAR-25-143 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.307, 93.310, 93.361, 93.399, 93.846, 93.853, 93.855, 93.865, 93.866, 93.989
- Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) PAR-25-207 · National Institutes of Health · January 7, 2028 · 93.242
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) PAR-25-346 · National Institutes of Health · January 7, 2028 · 93.121, 93.393, 93.394, 93.395, 93.396, 93.399
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) PAR-25-321 · National Institutes of Health · January 7, 2028 · 93.393, 93.394, 93.395, 93.396, 93.399
- Focused Technology Research and Development (R01 Clinical Trial Not Allowed) PAR-25-203 · National Institutes of Health · January 7, 2028 · 93.859
- Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) PAR-25-283 · National Institutes of Health · January 7, 2028 · 93.242
- Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) PAR-25-284 · National Institutes of Health · January 7, 2028 · 93.242
- Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) PAR-25-175 · National Institutes of Health · January 7, 2028 · 93.393, 93.394, 93.395
- Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) PAR-25-299 · National Institutes of Health · January 7, 2028 · 93.273, 93.307, 93.399
- Laboratories to Optimize Digital Health (R01 Clinical Trial Required) PAR-25-136 · National Institutes of Health · January 7, 2028 · 93.242
- Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) PA-25-093 · National Institutes of Health · January 7, 2028 · 93.846, 93.855
- Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) PAR-25-091 · National Institutes of Health · January 7, 2028 · 93.847
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) PAR-25-043 · National Institutes of Health · January 7, 2028 · 93.393, 93.396, 93.399
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) PAR-25-044 · National Institutes of Health · January 7, 2028 · 93.393, 93.396, 93.399
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) PA-25-172 · National Institutes of Health · January 7, 2028 · 93.393, 93.399
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) PAR-24-311 · National Institutes of Health · January 7, 2028 · 93.394, 93.395, 93.396
- Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) PAR-25-281 · National Institutes of Health · January 7, 2028 · 93.242, 93.313
- Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) PAR-25-282 · National Institutes of Health · January 7, 2028 · 93.242, 93.313
- Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) PAR-25-227 · National Institutes of Health · January 7, 2028 · 93.865
- Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required) PAR-25-289 · National Institutes of Health · January 7, 2028 · 93.242
- Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required) PAR-25-288 · National Institutes of Health · January 7, 2028 · 93.242
- NCMRR Early Career Research Award (R03 Clinical Trial Optional) PAR-25-124 · National Institutes of Health · January 7, 2028 · 93.865
- NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) PAR-25-358 · National Institutes of Health · January 7, 2028 · 93.867
- Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) PAR-25-287 · National Institutes of Health · January 7, 2028 · 93.242
- Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) PAR-25-286 · National Institutes of Health · January 7, 2028 · 93.242
- NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) PAR-25-251 · National Institutes of Health · January 7, 2028 · 93.855
- NICHD Small Research Grant Program (R03 Clinical Trial Required) PA-25-125 · National Institutes of Health · January 7, 2028 · 93.865
- NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) PAR-25-250 · National Institutes of Health · January 7, 2028 · 93.173
- NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed) PAR-25-027 · National Institutes of Health · January 7, 2028 · 93.121
- NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) PAR-25-105 · National Institutes of Health · January 7, 2028 · 93.121
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) PA-25-304 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) PA-25-306 · National Institutes of Health · January 7, 2028 · 93.113, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-25-301 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.143, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH Research Project Grant (Parent R01 Clinical Trial Required) PA-25-305 · National Institutes of Health · January 7, 2028 · 93.113, 93.143, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) PA-25-302 · National Institutes of Health · January 7, 2028 · 93.113, 93.143, 93.172, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.837, 93.838, 93.839, 93.840, 93.853, 93.855, 93.865, 93.866, 93.879
- Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) PAR-25-206 · National Institutes of Health · January 7, 2028 · 93.242
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-25-298 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.866, 93.867
- Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) PAR-25-185 · National Institutes of Health · January 7, 2028 · 93.121, 93.351, 93.865
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) PAR-25-292 · National Institutes of Health · January 7, 2028 · 93.242, 93.279, 93.307, 93.361, 93.393, 93.396, 93.399, 93.866
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) PAR-25-290 · National Institutes of Health · January 7, 2028 · 93.242
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) PAR-25-291 · National Institutes of Health · January 7, 2028 · 93.242
- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) RFA-HL-26-012 · National Institutes of Health · January 10, 2028 · 93.837, 93.855, 93.866, 93.867
- Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed) PAR-26-106 · National Institutes of Health · January 25, 2028 · 93.310, 93.352
- Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) PAR-25-383 · National Institutes of Health · January 28, 2028 · 93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) PAR-25-442 · National Institutes of Health · February 17, 2028 · 93.121, 93.242, 93.350, 93.855, 93.865, 93.867
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional) RFA-MH-28-145 · National Institutes of Health · February 17, 2028
- Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed) PAR-25-437 · National Institutes of Health · March 1, 2028 · 93.310
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) PA-25-168 · National Institutes of Health · May 4, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.313, 93.351, 93.361, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional) PAR-25-439 · National Institutes of Health · May 7, 2028 · 93.361
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) PAR-25-333 · National Institutes of Health · May 7, 2028 · 93.121
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-426 · National Institutes of Health · May 7, 2028 · 93.113, 93.121, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.865, 93.866, 93.867
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-425 · National Institutes of Health · May 7, 2028 · 93.113, 93.121, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) PA-25-423 · National Institutes of Health · May 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.859, 93.865, 93.866, 93.867
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) PA-25-422 · National Institutes of Health · May 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.273, 93.279, 93.286, 93.307, 93.310, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.867, 93.879
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) PA-25-424 · National Institutes of Health · May 7, 2028 · 93.113, 93.121, 93.233, 93.279, 93.310, 93.837, 93.838, 93.839, 93.840, 93.846, 93.859
- Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) PA-25-280 · National Institutes of Health · May 7, 2028 · 93.113, 93.173, 93.213, 93.233, 93.273, 93.286, 93.351, 93.847, 93.866, 93.867
- Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) PAR-25-374 · National Institutes of Health · May 7, 2028 · 93.866
- NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) PAR-25-447 · National Institutes of Health · May 8, 2028 · 93.233, 93.837, 93.838, 93.839, 93.840
- Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) PAR-27-127 · National Institutes of Health · May 25, 2028 · 93.242
- Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) PAR-26-115 · National Institutes of Health · May 26, 2028 · 93.847
- Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) PAR-26-121 · National Institutes of Health · May 26, 2028 · 93.859
- Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required) PAR-25-449 · National Institutes of Health · June 7, 2028 · 93.213
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed) PAR-27-112 · National Institutes of Health · June 12, 2028 · 93.866
- INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) RFA-OD-27-005 · National Institutes of Health · June 15, 2028 · 93.173, 93.233, 93.310, 93.350, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.865, 93.866
- INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) RFA-OD-27-003 · National Institutes of Health · June 15, 2028 · 93.121, 93.173, 93.233, 93.310, 93.351, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) RFA-OD-27-004 · National Institutes of Health · June 15, 2028 · 93.121, 93.173, 93.233, 93.242, 93.310, 93.350, 93.351, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.867, 93.879
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) PAR-27-053 · National Institutes of Health · June 16, 2028 · 93.279
- BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) RFA-NS-27-002 · National Institutes of Health · June 23, 2028 · 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.372, 93.853, 93.865, 93.866, 93.867
- Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed) PAR-27-021 · National Institutes of Health · July 1, 2028 · 93.310, 93.351, 93.855, 93.866
- Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) PAR-27-022 · National Institutes of Health · July 1, 2028 · 93.310, 93.351, 93.855, 93.859, 93.866, 93.867
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) PAR-27-076 · National Institutes of Health · July 7, 2028 · 93.113, 93.121, 93.173, 93.213, 93.233, 93.242, 93.273, 93.307, 93.310, 93.372, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879
- Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed) PAR-25-441 · National Institutes of Health · July 7, 2028 · 93.859
- Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) PAR-27-096 · National Institutes of Health · July 16, 2028 · 93.121, 93.307, 93.361, 93.866
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) PAR-25-450 · National Institutes of Health · July 20, 2028 · 93.350, 93.865
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) PAR-25-446 · National Institutes of Health · August 21, 2028 · 93.279
- Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional) RFA-DC-27-003 · National Institutes of Health · August 21, 2028 · 93.173, 93.286
- Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 · National Institutes of Health · August 25, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.286, 93.307, 93.313, 93.351, 93.361, 93.393, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.867, 93.879
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) PA-25-253 · National Institutes of Health · September 7, 2028 · 93.393, 93.399
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional) PAR-25-324 · National Institutes of Health · September 7, 2028 · 93.393, 93.394, 93.395, 93.396, 93.397, 93.399
- Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) PAR-25-415 · National Institutes of Health · September 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.398, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) PAR-25-414 · National Institutes of Health · September 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.398, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) PAR-27-026 · National Institutes of Health · September 25, 2028 · 93.279
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) PAR-25-444 · National Institutes of Health · September 25, 2028 · 93.397
- Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) RFA-ES-27-004 · National Institutes of Health · September 25, 2028 · 93.143
- NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34) PAR-26-033 · National Institutes of Health · September 25, 2028 · 93.859
- Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed) RFA-OD-25-011 · National Institutes of Health · September 26, 2028 · 93.351
- Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) RFA-OD-25-010 · National Institutes of Health · September 28, 2028 · 93.351
- Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed) PAR-27-068 · National Institutes of Health · October 2, 2028 · 93.859
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) RFA-NS-27-001 · National Institutes of Health · October 6, 2028 · 93.372
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed) RFA-AI-27-014 · National Institutes of Health · October 9, 2028 · 93.233, 93.279, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.867
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) RFA-NS-28-012 · National Institutes of Health · October 10, 2028 · 93.866
- Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) RFA-HL-27-010 · National Institutes of Health · October 13, 2028 · 93.233, 93.398, 93.837, 93.838, 93.839, 93.840, 93.855
- Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed) RFA-HD-27-007 · National Institutes of Health · October 20, 2028 · 93.242, 93.865
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) PAR-27-012 · National Institutes of Health · November 2, 2028 · 93.233, 93.837, 93.838, 93.839, 93.840
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) PAR-27-013 · National Institutes of Health · November 2, 2028 · 93.233, 93.837, 93.838, 93.839, 93.840
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) PAR-27-011 · National Institutes of Health · November 2, 2028 · 93.233, 93.837, 93.838, 93.839, 93.840
- CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed) PAR-27-075 · National Institutes of Health · November 5, 2028 · 93.279, 93.846, 93.855
- Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) PAR-25-362 · National Institutes of Health · November 5, 2028 · 93.865
- Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) RFA-HL-27-004 · National Institutes of Health · November 7, 2028 · 93.233, 93.837, 93.838, 93.839, 93.840
- Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) PAR-27-015 · National Institutes of Health · November 16, 2028 · 93.121, 93.307, 93.310, 93.313
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) PAR-26-134 · National Institutes of Health · November 22, 2028 · 93.396
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 · National Institutes of Health · November 30, 2028 · 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.372, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989
- Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) PAR-27-067 · National Institutes of Health · January 26, 2029 · 93.121, 93.172, 93.173, 93.242, 93.286, 93.351, 93.846, 93.853, 93.859, 93.866, 93.867
- Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) PAR-27-024 · National Institutes of Health · January 29, 2029 · 93.859
- Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) PAR-27-032 · National Institutes of Health · February 6, 2029 · 93.859
- BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) RFA-NS-28-010 · National Institutes of Health · February 8, 2029 · 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.372, 93.853, 93.865, 93.866, 93.867
- HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) RFA-DA-27-016 · National Institutes of Health · February 9, 2029 · 93.213, 93.273, 93.279, 93.866
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) RFA-NS-27-007 · National Institutes of Health · February 20, 2029 · 93.213, 93.233, 93.273, 93.279, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.865, 93.866, 93.867
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) PAR-28-063 · National Institutes of Health · February 20, 2029
- NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed) RFA-AR-28-001 · National Institutes of Health · March 1, 2029 · 93.313, 93.846
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) PAR-26-040 · National Institutes of Health · March 5, 2029 · 93.879
- Research Grants in Clinical Informatics (R01 Clinical Trial Optional) PAR-26-042 · National Institutes of Health · March 5, 2029 · 93.879
- NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required) PAR-27-065 · National Institutes of Health · March 9, 2029 · 93.853
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed) PAR-27-025 · National Institutes of Health · March 12, 2029 · 93.398
- Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional) PAS-27-028 · National Institutes of Health · March 16, 2029 · 93.279
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) PA-27-101 · National Institutes of Health · April 5, 2029 · 93.233, 93.242, 93.273, 93.307, 93.313, 93.350, 93.351, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 · National Institutes of Health · April 5, 2029 · 93.113, 93.121, 93.143, 93.172, 93.173, 93.233, 93.242, 93.273, 93.286, 93.307, 93.313, 93.350, 93.351, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed) PA-27-037 · National Institutes of Health · April 8, 2029 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.310, 93.398, 93.846, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) PAR-27-051 · National Institutes of Health · April 17, 2029 · 93.121, 93.242, 93.273, 93.279, 93.399, 93.853
- NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) PA-27-036 · National Institutes of Health · May 5, 2029 · 93.113, 93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.310, 93.313, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) PA-27-035 · National Institutes of Health · May 5, 2029 · 93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.310, 93.313, 93.361, 93.394, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.859, 93.866, 93.867
- Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) PAR-27-111 · National Institutes of Health · May 7, 2029 · 93.865
- NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 · National Institutes of Health · May 7, 2029 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.372, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989
- Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) PAR-28-090 · National Institutes of Health · May 25, 2029 · 93.121, 93.233, 93.242, 93.279, 93.307, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.865, 93.866, 93.989
- Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed) PAR-27-055 · National Institutes of Health · May 25, 2029 · 93.859
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) PAR-27-082 · National Institutes of Health · May 25, 2029 · 93.855
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) PAR-27-083 · National Institutes of Health · May 25, 2029 · 93.855
- NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) PA-27-034 · National Institutes of Health · May 25, 2029 · 93.113, 93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.310, 93.313, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH Research Program Projects (Parent P01 Clinical Trial Optional) PA-27-061 · National Institutes of Health · May 25, 2029 · 93.113, 93.172, 93.233, 93.273, 93.279, 93.307, 93.313, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.855, 93.866, 93.879
- NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) PAR-27-077 · National Institutes of Health · May 25, 2029 · 93.121, 93.172, 93.213, 93.242, 93.279, 93.286, 93.307, 93.310, 93.313, 93.361, 93.855, 93.859, 93.866, 93.867
- Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed) PAR-27-054 · National Institutes of Health · May 26, 2029 · 93.859
- Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional) PAR-27-056 · National Institutes of Health · May 30, 2029 · 93.859
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA-AI-27-018 · National Institutes of Health · June 20, 2029 · 93.121, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.313, 93.361, 93.393, 93.394, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.879
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-27-072 · National Institutes of Health · July 5, 2029 · 93.393, 93.394, 93.395, 93.396, 93.399, 93.853, 93.865, 93.867
- Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed) PAR-27-057 · National Institutes of Health · July 5, 2029 · 93.121
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) PAR-27-064 · National Institutes of Health · July 5, 2029 · 93.855
- NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) PAR-27-058 · National Institutes of Health · July 5, 2029 · 93.121
- Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) PAR-27-073 · National Institutes of Health · July 5, 2029 · 93.393
- Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) PAR-27-062 · National Institutes of Health · July 12, 2029 · 93.121, 93.286, 93.398, 93.853, 93.855
- Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed) PA-27-030 · National Institutes of Health · July 12, 2029 · 93.113, 93.121, 93.279, 93.310, 93.313, 93.847, 93.853, 93.859, 93.865, 93.867
- Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed) PAR-27-074 · National Institutes of Health · July 16, 2029 · 93.846
- Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional) PAR-28-093 · National Institutes of Health · July 16, 2029 · 93.279, 93.310, 93.681
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) PAR-28-022 · National Institutes of Health · September 25, 2029 · 93.121, 93.395
- Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) PAR-27-003 · National Institutes of Health · September 26, 2029 · 93.121, 93.172, 93.173, 93.273, 93.279, 93.473, 93.846, 93.853, 93.855, 93.859, 93.866, 93.867, 93.879
- Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) PAR-28-014 · National Institutes of Health · October 11, 2029 · 93.113, 93.393
- Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) PAR-27-090 · National Institutes of Health · November 5, 2029 · 93.242, 93.307, 93.361, 93.393, 93.853, 93.865, 93.866
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) PAR-28-056 · National Institutes of Health · November 5, 2029 · 93.393
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) PAR-28-042 · National Institutes of Health · November 16, 2029
- Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required) PAR-28-091 · National Institutes of Health · November 16, 2029 · 93.213, 93.473
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) PAR-28-072 · National Institutes of Health · November 16, 2029 · 93.867
- NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) RFA-EB-28-004 · National Institutes of Health · December 1, 2030 · 93.121, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867
Source scope
How the records were joined
Grants.gov postings were checked November 10, 2026. Notice details come from the official extract dated November 10, 2026 and the Grants.gov detail service where newer information was available. Deadline comparisons use the same opportunity ID, number and agency across notice versions. A revised date can reflect a new filing cycle. Read the current announcement and package for the deadline that applies to you.
USAspending history groups signed prime grant and cooperative-agreement obligations by exact Assistance Listing and fiscal year. Amendments can reduce a total. An obligation is a commitment. These figures cover the program’s reported transactions across awards and say nothing about available funds or the chance of an award under a particular notice. Missing program-year rows are shown as unavailable. Program figures should be read separately when a notice lists several programs.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.
Grants.gov extracts · Treasury data guide · Treasury API · Download the America.co snapshot